Serum uromodulin predicts graft failure in renal transplant recipients

Area of Science:

• Nephrology
• Transplantation Immunology
• Biomarker Discovery

Background:

• Kidney transplantation is a vital treatment for end-stage renal disease.
• Predicting graft loss is crucial for patient management and optimizing outcomes.
• Novel biomarkers are needed to improve risk stratification after transplantation.

Purpose of the Study:

• To evaluate serum uromodulin as a predictor of all-cause mortality and graft loss.
• To compare the predictive performance of uromodulin with established biomarkers.

Main Methods:

• Serum uromodulin concentrations were measured 1-3 months post-renal transplantation in 91 patients.
• All-cause mortality and graft loss were recorded as endpoints.
• Statistical analyses included hazard ratios and receiver-operating characteristic (ROC) analysis.

Main Results:

• Serum uromodulin predicted graft loss with an area under the curve (AUC) of 0.782.
• Uromodulin demonstrated comparable predictive performance to cystatin C, creatinine, and blood urea nitrogen (BUN).
• An optimal cut-off of 24.0 ng/ml for uromodulin yielded 90.0% sensitivity and 70.2% specificity for graft loss prediction.

Conclusions:

• Serum uromodulin is a valuable predictor of graft loss following kidney transplantation.
• Uromodulin offers equivalent predictive power to conventional biomarkers of glomerular filtration.
• This finding supports the potential clinical utility of serum uromodulin in post-transplant care.